Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria?-Reference-Cited by-同舟云学术

Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria?

Published:2024-07-09 Issue:7 Volume:68 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Gaviraghi Alberto¹²^ORCID,de Nicolò Amedeo³^ORCID,Venuti Francesco¹^ORCID,Stroffolini Giacomo²^ORCID,Quaranta Matilde¹,Cat Genova Elena³,Ponzetta Laura¹,Alladio Francesca²^ORCID,Marinaro Letizia¹^ORCID,D'Avolio Antonio³^ORCID,Calcagno Andrea¹^ORCID

Affiliation:

1. Unit of Infectious Diseases, Department of Medical Sciences, University of Torino at the Amedeo di Savoia Hospital, ASL Città di Torino, Turin, Italy

2. Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Via Don A. Sempreboni, Verona, Italy

3. Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy

Publisher

American Society for Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.00234-24

Reference18 articles.

1. The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease

2. Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution

3. Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin

4. Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis

5. Efficacy of Clarithromycin and Ethambutol forMycobacterium aviumComplex Pulmonary Disease. A Preliminary Study